AMA and CMS offer ICD-10 assessment

Carl Natale
by Carl Natale
AMA and CMS offer ICD-10 assessment

We keep saying that there needs to be more data before we can properly assess how the ICD-10 transition is affecting U.S. healthcare. So let's add two more opinions to the mix.

Which will come from Andy Slavitt, Centers for Medicare & Medicaid Services (CMS) Acting Administrator, and James L. Madara, MD,American Medical Association (AMA) Chief Executive Officer and Executive Vice President. They are at a discussion (“A Discussion with CMS & AMA on the Evolving Healthcare Market”) at the J.P. Morgan’s Healthcare Conference in San Francisco on Monday evening.

Since it's a bit early to quote any reports from the talks, I'm relying on tweets from Kerry Dooley Young, a healthcare writer for Congressional Quarterly.

First, she quotes Slavitt. He called the ICD-10 transition the "biggest event that no one heard about." Which shouldn't surprise or impress anyone. What else is he going to say?

But remember who else is in the room. Madara, who may not have presided over the AMA's vigorous opposition to ICD-10 but he certainly inherited it, offered this assessment of the ICD-10 transition: "Major glitches 'so far' avoided with ICD10 collaboration. Credits close work of his group, [CMS]."

Let's not drop the mic. But it's worth taking a moment to appreciate the less-than-vigorous tone the AMA is using when talking about the ICD-10 transition.

The rest of the remarks look like a pretty interesting assessment of the state of U.S. healthcare. It will be worth following up.